Simplify Logo

Full-Time

Senior Process Engineer

Posted on 5/5/2024

BillionToOne

BillionToOne

201-500 employees

Molecular diagnostics for prenatal and oncology testing

Biotechnology
Healthcare

Compensation Overview

$120k - $140kAnnually

+ Equity Options + Free Healthcare Options + 401k Match + Fully Paid Parental Leave

Senior, Expert

Menlo Park, CA, USA

Onsite position at Menlo Park location.

Category
Bioinformatics
Computational Biology
Genomics
Biology & Biotech
Required Skills
Python
Data Science
R
Requirements
  • Bachelor’s or Master’s (preferred) degree in biology, bioengineering, or related sciences
  • At least 5-6 years of experience with molecular biology techniques in a research or clinical laboratory
  • Proficiency in R or python
  • Strong Statistical Analysis skills
  • Strong Experience designing rigorous, well controlled studies
  • Experience with data presentation and technical report authoring
  • Experience working with GMP, ISO, or equivalent environments, with strong knowledge of Quality Management Systems and practices.
  • Excellent attention to detail
  • Effective written and verbal communication skills
  • Experience mentoring junior team members
  • Possess logical troubleshooting skills
  • Experience with automation or clinical laboratory experience is a bonus
Responsibilities
  • Source and evaluate external technologies which might benefit COGS, process throughput, assay performance, or other key operational metrics.
  • Develop the strategies to support 2-3X annual growth in commercial volume.
  • Build upon the existing statistical Process Control system to enable ever decreasing failure rates and ever increasing assay performance.
  • Mentor junior engineers and help to establish strong skills and industry best practices across the growing PE team.
  • Plan studies in conjunction with RnD to identify CPPs, process tolerances, and failure modes during late stage product development.
  • Work with Bioinformatics and data science to translate assay CQAs into impactful and actionable process monitoring tools.
  • Develop new data and information handling tools to aid in efficient sample processing within the clinical laboratory.
  • Apply six sigma, Design-for-quality, and 5S frameworks to existing or new processes to improve both capability, scalability, and quality of molecular diagnostic assays.
  • Support high throughput CLIA lab through troubleshooting instrumentation and re-qualifying instrumentation back into clinical use.
  • Identify root causes for process and instrument errors and develop long term solutions.

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair level, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne's business model centers on providing these diagnostic services directly to healthcare providers, generating revenue through the sale of their testing services. The goal of BillionToOne is to enhance the accuracy, efficiency, and accessibility of molecular testing, driven by a commitment to growth, equality, and teamwork in making a positive impact on healthcare.

Company Stage

Series C

Total Funding

$295.9M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

13%

1 year growth

23%

2 year growth

74%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $130M Series D funding round, led by PremjiInvest, positions BillionToOne for significant growth and expansion.
  • Partnerships with major companies like Johnson & Johnson enhance their credibility and market reach.
  • The appointment of Ross Taylor as CFO brings seasoned financial leadership, supporting the company's hypergrowth trajectory.

What critics are saying

  • The competitive landscape in molecular diagnostics is intense, requiring continuous innovation to maintain a leading position.
  • Dependence on healthcare providers for revenue could be impacted by changes in healthcare policies or economic downturns.

What makes BillionToOne unique

  • BillionToOne's QCT technology offers single base-pair resolution, providing unparalleled accuracy in molecular diagnostics.
  • Their focus on both prenatal screening and oncology testing allows them to address critical healthcare needs with specialized products like Northstar Select™ and Northstar Response™.
  • The company's mission-driven culture and commitment to accessibility set them apart in the biotech industry.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

INACTIVE